Therapeutic Agent for Fibrodysplasia Ossificans Progressiva

• 收藏
• 分享

专利权人:

Kyoto University;Sumitomo Dainippon Pharma Co., Ltd.

发明人:

Junya Toguchida,Makoto Ikeya,Akira Ohta,Kyosuke Hino

申请号：

US15546149

公开号：

US20180353485A1

申请日:

2016.01.25

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The present invention relates to a prophylactic or therapeutic agent for fibrodysplasia ossificans progressiva comprising as an active ingredient, at least one compound selected from the group consisting of rapamycin, temsirolimus, everolimus, ridaforolimus, TAFA93, umirolimus, olcorolimus, zotarolimus, and pharmaceutically acceptable salts thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/